Aspirin for Primary Prevention: New Meta-analysis Aspirin for Primary Prevention: New Meta-analysis

The review confirms no overall benefit of aspirin on reducing CV events, finds increased major bleeding risk, and no effect on cancer risk. Still, there is disagreement on how to apply these findings.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news